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Abstract 
Reported COVID‑19 deaths in Germany are relatively low as compared to many European countries. Among the 
several explanations proposed, an early and large testing of the population was put forward. Most current debates on 
COVID‑19 focus on the differences among countries, but little attention has been given to regional differences and 
diet. The low‑death rate European countries (e.g. Austria, Baltic States, Czech Republic, Finland, Norway, Poland, Slova‑
kia) have used different quarantine and/or confinement times and methods and none have performed as many early 
tests as Germany. Among other factors that may be significant are the dietary habits. It seems that some foods largely 
used in these countries may reduce angiotensin‑converting enzyme activity or are anti‑oxidants. Among the many 
possible areas of research, it might be important to understand diet and angiotensin‑converting enzyme‑2 (ACE2) 
levels in populations with different COVID‑19 death rates since dietary interventions may be of great benefit.
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Introduction
A novel strain of human coronaviruses, the severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2), 
named by the International Committee on Taxonomy of 
Viruses (ICTV) [1], has emerged and caused an infec-
tious disease referred to as “coronavirus disease 2019” 
(COVID-19) by the World Health Organization (WHO) 
[2]. COVID-19 has aggressively spread across the globe 
and over 160,000 deaths have been reported. However, 
there appears to be high- and low-death rate countries.
After the outbreak in China, COVID-19 has also 
affected Europe after becoming a pandemic. Interestingly, 
there is large variability across European countries in 
both incidence and mortality, and most current debates 
on COVID-19 focus on the differences among countries. 
German fatalities are strikingly low as compared to many 
European countries. Among the several explanations 
proposed, an early and large testing of the population was 
put forward [3].
However, little attention has been given to regional dif-
ferences and diet [4].
Biases to be considered
According to the Johns Hopkins coronavirus resource 
center (https ://coron aviru s.jhu.edu), one of the most 
important ways of measuring the burden of COVID-19 
is mortality. However, death rates are assessed differ-
ently between countries and there are many biases that 
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are almost impossible to assess. Differences in the mor-
tality rates depend on the characteristics of the health 
care system, the reporting method, whether or not deaths 
outside the hospital have been counted and other factors, 
many of which remain unknown. Countries through-
out the world have reported very different case fatality 
ratios—the number of deaths divided by the number of 
confirmed cases—but these numbers cannot be com-
pared at all due to biases. On the other hand, for many 
countries, the methodology reporting death rates in the 
different regions is standardized across the country.
European data on death rates per million 
inhabitants
We used the Johns Hopkins coronavirus resource center 
to assess death rates at the national level (https ://coron 
aviru s.jhu.edu). The current death rate per million peo-
ple in Europe shows different trends. Germany has a low 
death rate, but Austria, the Czech Republic, Poland, Slo-
vakia, the Baltic States and Finland have similar or lower 
rates. On the other hand, Belgium, France, Italy, Spain 
and the UK have higher rates (Fig. 1).
Large differences exist when assessing death rates 
within a country. In Germany, Bavaria started the earliest 
tests but was and still is the most affected region (Fig. 2). 
Death rates per million range from 8 in Mecklenburg-
Vorpommern to 87 in Bavaria.
In Switzerland, the French and Italian speaking cantons 
have a far higher death rate than the German-speaking 
ones (Fig. 3) (Office fédéral de la santé publique, Switzer-
land, https ://www.bag.admin .ch/bag/fr/home.html).
In high-rate countries such as Spain, large variations 
also exist within the country, but the numbers range from 
115 in Murcia to over 1000 in Madrid.
Is diet partly involved in different death rates 
between countries?
Most diseases exhibit large geographical variations which 
frequently remain unexplained despite abundant research 
[5]. COVID-19 will not be an exception. Though the 
more relevant factors are likely to be seasonal variations, 
immunity, cross-immunity, intensity, timing of measures 
[6], type, onset, duration and measures of protection, 
other factors like environment or nutrition should not be 
overlooked. Obesity, a risk factor of mortality in COVID-
19, suggests the importance of nutrition [7].
The “low-rate” European countries have used different 
quarantine and/or confinement times and methods and 
Fig. 1 COVID‑19 deaths per million inhabitants in Europe (April 17, 2020). For France, deaths included hospital and extra‑hospital deaths
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none have performed as many early tests as Germany. 
Thus, although the German testing approach is very 
important [3], other factors may also be significant.
Immunity in COVID‑19 and ageing
Although there are large differences between countries 
in death rates, the age-dependent severity of COVID-19 
is similar between Asian, European and American coun-
tries. The rate of deaths is increased in the older popula-
tion. Globally, there are risk factors for death including 
obesity and type 2 diabetes.
A strong relationship between hyperglycemia, 
impaired insulin pathway, and cardiovascular disease in 
type 2 diabetes is linked to oxidative stress and inflam-
mation [8]. Lipid metabolism has an important role to 
play in obesity, diabetes and its multi-morbidities, and 
the ageing process [9]. Dietary fatty acids have a signifi-
cant role in immune responses [10].
Many foods have an antioxidant activity [11–13]. Res-
veratrol, present in many foods [14], is an inhibitor of 
MERS-Coronavirus infection [15].
Fig. 2 Regional COVID‑19 death rates per million in four European countries
Fig. 3 COVID‑19 rates in Switzerland (Office fédéral de la santé publique). Cas confirmés en laboratoire (laboratory confirmed cases), distribution 
géographique (geographical distibution), cas décédés (death rate)
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Angiotensin‑converting enzyme 2 (ACE‑2)
The angiotensin-converting enzyme (ACE2) has multi-
ple physiological roles: a negative regulator of the renin-
angiotensin system, facilitator of amino acid transport, 
and the SARS-CoV and SARS-CoV-2 receptor [16]. ACE 
converts angiotensin I to angiotensin II but ACE2 cataly-
ses the conversion of angiotensin II to angiotensin and is 
also the main entry point for coronavirus 2 into cells.
Differences between countries in ACE have been asso-
ciated with genetic patterns. The ACE D allele increased 
risk of vasculitis [17] or hypertension [18]. The ACE I/D 
polymorphism is involved in the onset of type 2 diabe-
tes [19] and might be associated with susceptibility to 
peripheral vascular diseases in the Asian population [20].
However, dietary patterns have a strong effect on ACE 
levels. A high-saturated fat diet increases ACE [21]. Many 
foods have an ACE-inhibitory activity [22–24]. Anti-
oxidant activities and ACE inhibition have been largely 
found in many foods [25]. Moreover, ACE levels in blood 
are highly and rapidly sensitive to food intake [26].
Identifying whether countries with high or low ACE 
activity have different death rates would be of great inter-
est in understanding the clinical importance of interven-
tions. However, the available evidence, in particular from 
human studies, does not seem to support the hypothesis 
that inhibitors of ACE or renin-angiotensin–aldosterone 
(ACEI/ARB) drugs increase the ACE2 expression and the 
risk of COVID-19 [27]. This might suggest that changes 
in ACE expression (inhibition/stimulation) might not be 
as relevant as previously thought and other diet-related 
changes might be more (or equally) important.
Possible interactions between diet and COVID‑19 death 
rate
Germany, Austria, Croatia, the Czech Republic, Poland, 
Slovakia, the Baltic States and German-speaking Swiss 
cantons exhibit lower COVID-19 mortality rates than 
France, Italy, Spain, and the French and Italian speaking 
Swiss cantons. Among many factors, diet differs consid-
erably between these low- or high-mortality countries.
It appears that death rates in Germany are higher in the 
two Southern Regions as well as in Saarland than else-
where. Baden-Wurttemberg and Saarland are in close 
contact with Alsace (France), and the higher infection 
rate may be due to the high cross-border traffic of the 
French. However, this was not the case for Rhineland-
Palatinate (lower death rate), possibly because the East 
Region of France was contaminated later. In addition, 
Saarland is a special case as half of the deaths, unlike in 
the other German states, occurred in only a few long-
term care facilities where a high number of people were 
infected in a short time and all deaths during the episode 
were attributed to Corona without autopsies being made. 
This potential French-based contamination does not 
apply for Bavaria (earliest German region to be contami-
nated and highest death rate). Diet differs within Ger-
many, the southern states traditionally having a higher 
fat-rich diet. Diet is not normally distributed within 
country/region, which can be an additional argument in 
favour of the uneven distribution of mortality.
Nutrition may therefore play a role in the immune 
defense against COVID-19 and may explain some of the 
differences seen in COVID-19 across Europe. It will be 
needed to test dietary differences between low and high-
rate countries. Foods with potent antioxidant or anti ACE 
activity—like uncooked or fermented cabbage [28–30]—
are largely consumed in low-death rate European coun-
tries, Korea and Taiwan, and might be considered in the 
low prevalence of deaths.
Although it is difficult to compare health systems and 
death reporting across European countries, Bulgaria, 
Greece and Romania have very low death rates. This 
might also be associated with diet since cabbage (Roma-
nia) and fermented milk (Bulgaria and Greece) are com-
mon foods. The latter food is a known ACE natural 
inhibitor [31]. Turkey, another apparently low-death rate 
country, also consumes a lot of cabbage and fermented 
milk products.
Another example may be the food supply chain. The 
increasing availability of foods from big retail is a revo-
lutionary event that has impacted crops (favouring 
those that have the best ratio of effectiveness over costs 
of production) and health at a population-size level. In 
particular, such a change in food availability has altered 
alimentary habits—promoting sugar-enriched, vitamin-
depauperated foods—and has become one of the causes 
of the obesity epidemic, especially among adolescents. 
These foods come from centralized farms in selected 
areas of the world that are distributed around the planet, 
elongating the supply chain of food. The impact of long 
supply chain of food on health is measurable by an 
increase in metabolic syndrome and insulin resistance 
[32]. Therefore, rural areas that are more prone to short 
supply food may have been able to better tolerate the 
COVID-19 pandemia, with a lower death toll. These con-
siderations may be partly involved in lower death rates in 
Southern Italy compared to the Northern part.
Conclusions
Understanding the within and between country differ-
ences in COVID-19 will be of paramount importance in 
understanding COVID-19 risk and protective factors, 
and will eventually help to control the epidemics.
We acknowledge that many factors may play a role 
in the extension and severity of COVID-19, such as 
trained immunity of the population, early and fast 
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education, rapid organization and adaptation of the hos-
pitals and the public, preparedness for pandemics and 
public hygiene. Diet represents only one of the possible 
causes of the COVID-19 epidemic and its importance 
needs to be better assessed.
Abbreviations
ACE: Angiotensin converting enzyme; COVID‑19: Coronavirus 19 disease; 
MERS: Middle East Respiratory Syndrome; SARS: Severe acute respiratory syn‑
drome; SARS‑Cov‑2: Severe acute respiratory syndrome coronavirus 2.
Acknowledgements
ARIA group: Amir Hamzah Abdul Latiff, Baharudin Abdullah, Werner Aberer, 
Nancy Abusada, Ian Adcock, Alejandro Afani, Ioana Agache, Xenofon 
Aggelidis, Jenifer Agustin, Cezmi Akdis, Mübeccel Akdis, Mona Al‑Ahmad, 
Abou Al‑Zahab Bassam, Oscar Aldrey‑Palacios, Emilio Alvarez Cuesta, Ashraf 
Alzaabi, Salma Amad, Gene Ambrocio, Isabella Annesi‑Maesano, Ignacio 
Ansotegui, Josep Anto, Hasan Arshad, Maria Cristina Artesani, Estrella Asayag, 
Francesca Avolio, Khuzama Azhari, Ilaria Baiardini, Nissera Bajrović, Petros 
Bakakos, Sergio Bakeyala Mongono, Christine Balotro‑Torres, Sergio Barba, 
Cristina Barbara, Elsa Barbosa, Bruno Barreto, Joan Bartra, Eric D. Bateman, 
Lkhagvaa Battur, Anna Bedbrook, Martín Bedolla Barajas, Bianca Beghé, 
Elizabeth Bel, Ali Ben Kheder, Mikael Benson, Camelia Berghea, Karl‑Christian 
Bergmann, David Bernstein, Mike Bewick, Slawomir Bialek, Artur Białoszewski, 
Thomas Bieber, Nils Billo, Maria Beatrice Bilo, Carsten Bindslev‑Jensen, Leif 
Bjermer, Hubert Blain, Malgorzata Bochenska Marciniak, Christine Bond, Attilio 
Boner, Matteo Bonini, Sergio Bonini, Sinthia Bosnic‑Anticevich, Isabelle Bosse, 
Sofia Botskariova, Jacques Bouchard, Louis‑Philippe Boulet, Rodolphe Bourret, 
Philippe Bousquet, Fulvio Braido, Andrew Briggs, Christopher Brightling, Jan 
Brozek, Roland Buhl, Roxana Bumbacea, María Teresa Burguete Cabañas, 
Andrew Bush, William W. Busse, Jeroen Buters, Fernan Caballero‑Fonseca, 
Moïses A. Calderon, Mario Calvo, Paulo Camargos, Thierry Camuzat, Antonio 
Cano, G. Walter Canonica, Arnaldo Capriles‑Hulett, Luis Caraballo, Vicky 
Cardona, Kai‑Hakon Carlsen, Jorge Caro, Warner Carr, Fredelita Carreon‑Asun‑
cion, Ana Maria Carriazo, Thomas Casale, Mary Ann Castor, Elizabeth Castro, 
Lorenzo Cecchi, Alfonso Cepeda Sarabia, Ramanathan Chandrasekharan, 
Yoon‑Suk Chang, Victoria Chato‑Andeza, Lida Chatzi, Christina Chatzidaki, Niels 
H. Chavannes, Yuzhi Chen, Lei Cheng, Tomas Chivato, Ekaterine Chkhartishvili, 
George Christoff, Henry Chrystyn, Derek K. Chu, Antonio Chua, Alexander 
Chuchalin, Kian Fan Chung, Alberto Cicerán, Cemal Cingi, Giorgio Ciprandi, 
Ieva Cirule, Ana Carla Coelho, Jannis Constantinidis, Jaime Correia de Sousa, 
Elisio Costa, David Costa, María del Carmen Costa Domínguez, André Coste, 
Linda Cox, Alvaro A. Cruz, John Cullen, Adnan Custovic, Biljana Cvetkovski, 
Wienczyslawa Czarlewski, Gennaro D’Amato, Jane da Silva, Ronald Dahl, 
Sven‑Erik Dahlen, Vasilis Daniilidis, Louei Darjazini Nahhas, Ulf Darsow, Frédéric 
de Blay, Eloisa De Guia, Chato de los Santos, Esteban De Manuel Keenoy, 
Govert De Vries, Diana Deleanu, Pascal Demoly, Judah Denburg, Philippe 
Devillier, Alain Didier, Maria Dimou, Anh Tuan Dinh‑Xuan, Ratko Djukanovic, 
Dejan Dokic, Margarita Gabriela Domínguez Silva, Habib Douagui, Nikolaos 
Douladiris, Maria Doulaptsi, Gérard Dray, Ruta Dubakiene, Stephen Durham, 
Mark Dykewicz, Didier Ebo, Natalija Edelbaher, Patrik Eklund, Yehia El‑Gamal, 
Zeinab A. El‑Sayed, Shereen S. El‑Sayed, Magda El‑Seify, Regina Emuzyte, 
Lourdes Enecilla, Heidilita Espinoza, Jesús Guillermo Espinoza Contreras, John 
Farrell, Lenora Fernandez, Antje Fink Wagner, Alessandro Fiocchi, Wytske J. 
Fokkens, Jean‑François Fontaine, Francesco Forastiere, Jose Miguel Fuentes 
Pèrez, Emily Gaerlan–Resureccion, Mina Gaga, José Luis Gálvez Romero, 
Amiran Gamkrelidze, Alexis Garcia, Cecilia Yvonne García Cobas, María de la 
Luz Hortensia García Cruz, Jacques Gayraud, Bilun Gemicioglu, Sonya Genova, 
José Gereda, Roy Gerth van Wijk, Maximiliano Gomez, Sandra González Diaz, 
Maia Gotua, Christos Grigoreas, Ineta Grisle, Marta Guidacci, Nick Guldemond, 
Zdenek Gutter, Antonieta Guzmán, Tari Haahtela, Ramsa Halloum, Eckard 
Hamelmann, Suleiman Hammadi, Richard Harvey, Joachim Heinrich, Adnan 
Hejjaoui, Birthe Hellquist‑Dahl, Luiana Hernández Velázquez, Mark Hew, Elham 
Hossny, Peter Howarth, Martin Hrubiško, Yunuen Rocío Huerta Villalobos, Marc 
Humbert, Michael Hyland, Guido Iaccarino, Moustafa Ibrahim, Maddalena 
Illario, Natalia Ilyina, Carla Irani, Zhanat Ispayeva, Juan Carlos Ivancevich, 
Edgardo Jares, Deborah Jarvis, Ewa Jassem, Klemen Jenko, Rubén Darío 
Jiméneracruz  Uscanga, Sebastian Johnston, Guy Joos, Maja Jošt, Kaja Julge, 
Ki‑Suck Jung, Jocelyne Just, Marek Jutel, Igor Kaidashev, Omer Kalayci, Fuat 
Kalyoncu, Jeni Kapsali, Przemyslaw Kardas, Jussi Karjalainen, Carmela A. Kasala, 
Michael Katotomichelakis, Bennoor Kazi, Thomas Keil, Paul Keith, Musa Khaitov, 
Nikolai Khaltaev, You‑Young Kim, Jorg Kleine‑Tebbe, Ludger Klimek, Bernard 
Koffi N’Goran, Evangelia Kompoti, Peter Kopač, Gerard Koppelman, Anja Koren 
Jeverica, Mitja Košnik, Kosta V. Kostov, Marek L. Kowalski, Tanya Kralimarkova, 
Karmen Kramer Vrščaj, Helga Kraxner, Samo Kreft, Vicky Kritikos, Dmitry Kudlay, 
Inger Kull, Piotr Kuna, Maciej Kupczyk, Violeta Kvedariene, Marialena 
Kyriakakou, Nika Lalek, Stephen Lane, Désiree Larenas‑Linnemann, Amir Latiff, 
Susanne Lau, Daniel Laune, Jorge Lavrut, Lan Le, Marcus Lessa, Michael Levin, 
Jing Li, Philip Lieberman, Giuseppe Liotta, Brian Lipworth, Xuandao Liu, 
Rommel Lobo, Karin C. Lodrup Carlsen, Carlo Lombardi, Renaud Louis, Stelios 
Loukidis, Olga Lourenço, Jorge A. Luna Pech, Bojan Madjar, Antoine Magnan, 
Bassam Mahboub, Alpana Mair, Yassin Mais, Anke‑Hilse Maitland van der Zee, 
Mika Makela, Michael Makris, Hans‑Jorgen Malling, Mariana Mandajieva, Patrick 
Manning, Manolis Manousakis, Pavlos Maragoudakis, Gailen Marshall, Pedro 
Martins, Mohammad Reza Masjedi, Jorge F. Máspero, Juan José Matta Campos, 
Marcus Maurer, Sandra Mavale‑Manuel, Cem Meço, Erik Melén, Elisabete 
Melo‑Gomes, Eli O. Meltzer, Enrica Menditto, Andrew Menzies‑Gow, Hans 
Merk, Jean‑Pierre Michel, Neven Miculinic, Luís Midão, Florin Mihaltan, 
Kuitunen Mikael, Nikolaos Mikos, Branislava Milenkovic, Dimitrios Mitsias, 
Bassem Moalla, Giuliana Moda, María Dolores Mogica Martínez, Yousser 
Mohammad, Mostafa Moin, Mathieu Molimard, Isabelle Momas, Alessandro 
Monaco, Steve Montefort, Dory Mora, Mario Morais‑Almeida, Ralph Mösges, 
Badr Eldin Mostafa, Joaquim Mullol, Lars Münter, Antonella Muraro, Ruth 
Murray, Tihomir Mustakov, Robert Naclerio, Rachel Nadif, Alla Nakonechna, 
Leyla Namazova‑Baranova, Gretchen Navarro‑Locsin, Hugo Neffen, Kristof 
Nekam, Angelos Neou, Laurent Nicod, Verena Niederberger‑Leppin, Marek 
Niedoszytko, Antonio Nieto, Ettore Novellino, Elizabete Nunes, Dieudonné 
Nyembue, Robyn O’Hehir, Cvetanka Odjakova, Ken Ohta, Yoshitaka Okamoto, 
Kimi Okubo, Brian Oliver, Gabrielle L. Onorato, Maria Pia Orru, Solange 
Ouédraogo, Kampadilemba Ouoba, Pier Luigi Paggiaro, Aris Pagkalos, S. P. 
Palaniappan, Isabella Pali‑Schöll, Susanna Palkonen, Stephen Palmer, Carmen 
Panaitescu Bunu, Petr Panzner, Nikos G. Papadopoulos, Vasilis Papanikolaou, 
Alberto Papi, Bojidar Paralchev, Giannis Paraskevopoulos, Hae Sim Park, 
Giovanni Passalacqua, Vincenzo Patella, Ian Pavord, Ruby Pawankar, Soren 
Pedersen, Susete Peleve, Ana Pereira, Tamara Pérez, Oliver Pfaar, Nhân 
Pham‑Thi, Bernard Pigearias, Isabelle Pin, Konstantina Piskou, Constantinos 
Pitsios, Kostas Pitsios, Davor Plavec, Dagmar Poethig, Wolfgang Pohl, Antonija 
Poplas Susic, Todor A. Popov, Fabienne Portejoie, Paul Potter, Lars Poulsen, 
Alexandra Prados‑Torres, Fotis Prarros, David Price, Emmanuel Prokopakis, 
Robert Puy, Klaus Rabe, Filip Raciborski, Josephine Ramos, Marysia T. Recto, 
Shereen M. Reda, Frederico Regateiro, Norbert Reider, Sietze Reitsma, Susana 
Repka‑Ramirez, Janet Rimmer, Daniela Rivero Yeverino, José Angelo Rizzo, 
Carlos Robalo‑Cordeiro, Graham Roberts, Nicolas Roche, Mónica Rodríguez 
González, Eréndira Rodríguez Zagal, Christine Rolland, Regina Roller‑Wirns‑
berger, Miguel Roman Rodriguez, Antonino Romano, Philippe Rombaux, Joel 
Romualdez, Jose Rosado‑Pinto, Nelson Rosario, Lanny Rosenwasser, 
Menachem Rottem, Philip Rouadi, Nikoleta Rovina, Irma Rozman Sinur, 
Mauricio Ruiz, Lucy Tania Ruiz Segura, Dermot Ryan, Hironori Sagara, Daiki 
Sakai, Daiju Sakurai, Wafaa Saleh, Johanna Salimaki, Husain Salina, Konstanti‑
nos Samitas, Boleslaw Samolinski, María Guadalupe Sánchez Coronel, Mario 
Sanchez‑Borges, Jaime Sanchez‑Lopez, Codrut Sarafoleanu, Faradiba Sarquis 
Serpa, Joaquin Sastre‑Dominguez, Glenis Scadding, Sophie Scheire, Peter 
Schmid‑Grendelmeier, Juan Francisco Schuhl, Holger Schunemann, Maria 
Schvalbová, Nicola Scichilone, Cecilia Sepúlveda, Elie Serrano, Aziz Sheikh, 
Mike Shields, Vasil Shishkov, Nikos Siafakas, Alexander Simeonov, Estelle F. 
Simons, Juan Carlos Sisul, Brigita Sitkauskiene, Ingelbjorg Skrindo, Tanja Soklič 
Košak, Dirceu Solé, Talant Sooronbaev, Manuel Soto‑Martinez, Milan Sova, 
François Spertini, Otto Spranger, Sofia Stamataki, Lina Stefanaki, Cristiana 
Stellato, Rafael Stelmach, Peter Sterk, Timo Strandberg, Petra Stute, Abirami 
Subramaniam, Charlotte Suppli Ulrik, Michael Sutherland, Silvia Sylvestre, 
Aikaterini Syrigou, Luis Taborda Barata, Nadejda Takovska, Rachel Tan, Frances 
Tan, Vincent Tan, Ing Ping Tang, Masami Taniguchi, Line Tannert, Jessica 
Tattersall, Maria do Ceu Teixeira, Carel Thijs, Mike Thomas, Teresa To, Ana Maria 
Todo‑Bom, Alkis Togias, Peter‑Valentin Tomazic, Sanna Toppila‑Salmi, Elina 
Toskala, Massimo Triggiani, Nadja Triller, Katja Triller, Ioanna Tsiligianni, 
Ruxandra Ulmeanu, Jure Urbancic, Marilyn Urrutia Pereira, Martina Vachova, 
Felipe Valdés, Rudolf Valenta, Marylin Valentin Rostan, Antonio Valero, Arunas 
Valiulis, Mina Vallianatou, Erkka Valovirta, Michiel Van Eerd, Eric Van Ganse, 
Marianne van Hage, Olivier Vandenplas, Tuula Vasankari, Dafina Vassileva, Maria 
Page 6 of 7Bousquet et al. Clin Transl Allergy           (2020) 10:16 
Teresa Ventura, Cécilia Vera‑Munoz, Dilyana Vicheva, Pakit Vichyanond, Petra 
Vidgren, Giovanni Viegi, Claus Vogelmeier, Leena Von Hertzen, Theodoros 
Vontetsianos, Dimitris Vourdas, Martin Wagenmann, Samantha Walker, Dana 
Wallace, De Yun Wang, Susan Waserman, Magnus Wickman, Sian Williams, 
Dennis Williams, Nicola Wilson, Kent Woo, John Wright, Piotr Wroczynski, 
Paraskevi Xepapadaki, Plamen Yakovliev, Masao Yamaguchi, Kwok Yan, Yoke 
Yeow Yap, Barbara Yawn, Panayiotis Yiallouros, Arzu Yorgancioglu, Shigemi 
Yoshihara, Ian Young, Osman B. Yusuf, Asghar Zaidi, Fares Zaitoun, Heather Zar, 
Mario Zernotti, Luo Zhang, Nanshan Zhong, Mihaela Zidarn, Torsten Zuberbier, 
Celia Zubrinich.
Authors’ contributions
JB proposed the concept and discussed it with JMA and WC. J Bousquet and 
JA wrote the paper. All the other authors were requested to comment on 
the concept and to review the paper. All authors read and approved the final 
manuscript.
Funding
MASK‑air, ARIA.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
Not applicable.
Consent for publication
All authors gave their informed consent.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Charité Universitätsmedizin Berlin, Humboldt‑Universität zu Berlin, Berlin, 
Germany. 2 Department of Dermatology and Allergy, Berlin Institute of Health, 
Comprehensive Allergy Center, Berlin, Germany. 3 MACVIA‑France, Montpellier, 
France. 4 CHU Montpellier, 273 Avenue d’Occitanie, 34090 Montpellier, France. 
5 Centre for Research in Environmental Epidemiology (CREAL), ISGlobAL, 
Barcelona, Spain. 6 IMIM (Hospital del Mar Research Institute), Barcelona, Spain. 
7 Universitat Pompeu Fabra (UPF), Barcelona, Spain. 8 CIBER Epidemiología 
y Salud Pública (CIBERESP), Barcelona, Spain. 9 Department of Advanced 
Biomedical Sciences, Federico II University, Naples, Italy. 10 MASK‑air, Montpel‑
lier, France. 11 Medical Consulting Czarlewski, Levallois, France. 12 Helsinki 
University, Helsinki, Finland. 13 Swiss Institute of Allergy and Asthma Research 
(SIAF), University of Zurich, Davos, Switzerland. 14 Department of Geriatrics, 
Montpellier University Hospital, Montpellier, France. 15 EA 2991, Euromov, 
University Montpellier, Montpellier, France. 16 Personalized Medicine Clinic 
Asthma & Allergy, Humanitas University, Humanitas Research Hospital, 
Rozzano, Milan, Italy. 17 Allergy Section, Department of Internal Medicine, Hos‑
pital Vall d’Hebron & ARADyAL research network, Barcelona, Spain. 18 ProAR 
– Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil. 
19 WHO GARD Planning Group, Salvador, Brazil. 20 Division for Health Innova‑
tion, Campania Region, Naples, Italy. 21 Federico II University Hospital Naples 
(R&D and DISMET), Naples, Italy. 22 Clinica Santa Isabel, Servicio de Alergia e 
Immunologia, Buenos Aires, Argentina. 23 Department of Clinical Immunol‑
ogy, Wrocław Medical University, Wrocław, Poland. 24 Center for Rhinology 
and Allergology, Wiesbaden, Germany. 25 Division of Internal Medicine, 
Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, 
Łódź, Poland. 26 KYomed INNOV, Montpellier, France. 27 Center of Excellence 
in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México 
City, Mexico. 28 Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic; 
Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, Univer‑
sity of Barcelona, Barcelona, Spain. 29 Division of Infection, Immunity & Respira‑
tory Medicine, Royal Manchester Children’s Hospital, University of Manchester, 
Manchester, UK. 30 Allergy Department, 2nd Pediatric Clinic, Athens General 
Children’s Hospital “P&A Kyriakou,”, University of Athens, Athens, Greece. 
31 Department of Otorhinolaryngology, Head and Neck Surgery, Section 
of Rhinology and Allergy, University Hospital Marburg, Phillipps‑Universität 
Marburg, Marburg, Germany. 32 Department of Prevention of Envinronmen‑
tal Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland. 
33 Institute of Clinical Medicine & Institute of Health Sciences, Vilnius University 
Faculty of Medicine, Vilnius, Lithuania. 34 Department of Pulmonary Diseases, 
Celal Bayar University, Faculty of Medicine, Manisa, Turkey. 
Received: 4 May 2020   Accepted: 16 May 2020
References
 1. Coronaviridae Study Group of the International Committee on Taxonomy 
of Viruses. The species Severe acute respiratory syndrome‑related coro‑
navirus: classifying 2019‑nCoV and naming it SARS‑CoV‑2. Nat Microbiol. 
2020. https ://doi.org/10.1038/s4156 4‑020‑0695‑z (Epub ahead of prin).
 2. Bousquet J, Akdis C, Jutel M, Bachert C, Klimek L, Agache I, et al. Intranasal 
corticosteroids in allergic rhinitis in COVID‑19 infected patients: an ARIA‑
EAACI statement. Allergy. 2020. https ://doi.org/10.1111/all.14302 .
 3. Stafford N. Covid‑19: Why Germany’s case fatality rate seems so low. BMJ. 
2020;369:m1395.
 4. Bousquet J, Czarlewski W, Blain H, Zuberbier T, Anto J. Rapid response: 
why Germany’s case fatality rate seems so low: is nutrition another pos‑
sibility. BMJ. 2020. https ://www.bmj.com/conte nt/369/bmj.m1395 /rr‑12.
 5. Sunyer J, Jarvis D, Pekkanen J, Chinn S, Janson C, Leynaert B, et al. 
Geographic variations in the effect of atopy on asthma in the Euro‑
pean Community Respiratory Health Study. J Allergy Clin Immunol. 
2004;114(5):1033–9.
 6. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the 
transmission dynamics of SARS‑CoV‑2 through the postpandemic period. 
Science. 2020;368:860–8.
 7. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, 
et al. High prevalence of obesity in severe acute respiratory syndrome 
coronavirus‑2 (SARS‑CoV‑2) requiring invasive mechanical ventilation. 
Obesity. 2020. https ://doi.org/10.1002/oby.22831 .
 8. Guzik TJ, Cosentino F. Epigenetics and immunometabolism in diabetes 
and aging. Antioxid Redox Signal. 2018;29(3):257–74.
 9. Miedema MD, Maziarz M, Biggs ML, Zieman SJ, Kizer JR, Ix JH, et al. 
Plasma‑free fatty acids, fatty acid‑binding protein 4, and mortality 
in older adults (from the Cardiovascular Health Study). Am J Cardiol. 
2014;114(6):843–8.
 10. Radzikowska U, Rinaldi AO, Celebi Sozener Z, Karaguzel D, Wojcik M, 
Cypryk K, et al. The influence of dietary fatty acids on immune responses. 
Nutrients. 2019;11(12):2990.
 11. Jain S, Buttar HS, Chintameneni M, Kaur G. Prevention of cardiovascular 
diseases with anti‑inflammatory and anti‑oxidant nutraceuticals and 
herbal products: an overview of pre‑clinical and clinical studies. Recent 
Pat Inflamm Allergy Drug Discov. 2018;12(2):145–57.
 12. Razmpoosh E, Javadi M, Ejtahed HS, Mirmiran P. Probiotics as beneficial 
agents in the management of diabetes mellitus: a systematic review. 
Diabetes Metab Res Rev. 2016;32(2):143–68.
 13. Serino A, Salazar G. Protective role of polyphenols against vascular inflam‑
mation, aging and cardiovascular disease. Nutrients. 2018;11(1):53.
 14. Malaguarnera L. Influence of resveratrol on the immune response. Nutri‑
ents. 2019;11(5):946.
 15. Lin SC, Ho CT, Chuo WH, Li S, Wang TT, Lin CC. Effective inhibition of 
MERS‑CoV infection by resveratrol. BMC Infect Dis. 2017;17(1):144.
 16. Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. 
Angiotensin converting enzyme 2: SARS‑CoV‑2 receptor and regulator of 
the renin‑angiotensin system. Circ Res. 2020;126:1456–74.
 17. Turgut S, Turgut G, Atalay EO, Atalay A. Angiotensin‑converting enzyme 
I/D polymorphism in Behcet’s disease. Med Princ Pract. 2005;14(4):213–6.
 18. Di Pasquale P, Cannizzaro S, Paterna S. Does angiotensin‑converting 
enzyme gene polymorphism affect blood pressure? Findings after 6 years 
of follow‑up in healthy subjects. Eur J Heart Fail. 2004;6(1):11–6.
 19. Muthumala A, Gable DR, Palmen J, Cooper JA, Stephens JW, Miller GJ, 
et al. Is the influence of variation in the ACE gene on the prospective risk 
of Type 2 diabetes in middle‑aged men modified by obesity? Clin Sci. 
2007;113(12):467–72.
 20. Han C, Han XK, Liu FC, Huang JF. Ethnic differences in the association 
between angiotensin‑converting enzyme gene insertion/deletion poly‑
morphism and peripheral vascular disease: a meta‑analysis. Chronic Dis 
Transl Med. 2017;3(4):230–41.
Page 7 of 7Bousquet et al. Clin Transl Allergy           (2020) 10:16  
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 21. Schuler R, Osterhoff MA, Frahnow T, Seltmann AC, Busjahn A, Kabisch S, 
et al. High‑saturated‑fat diet increases circulating angiotensin‑converting 
enzyme, which is enhanced by the rs4343 polymorphism defining 
persons at risk of nutrient‑dependent increases of blood pressure. J Am 
Heart Assoc. 2017;6(1):e004465.
 22. Iwaniak A, Minkiewicz P, Darewicz M. Food‑originating ACE inhibitors, 
including antihypertensive peptides, as preventive food components 
in blood pressure reduction. Comprehens Rev Food Sc Food safety. 
2014;13(2):111–34.
 23. Ganguly A, Sharma K, Majumder K. Food‑derived bioactive peptides and 
their role in ameliorating hypertension and associated cardiovascular 
diseases. Adv Food Nutr Res. 2019;89:165–207.
 24. Fan H, Liao W, Wu J. Molecular interactions, bioavailability, and cellular 
mechanisms of angiotensin‑converting enzyme inhibitory peptides. J 
Food Biochem. 2019;43(1):e12572.
 25. Huang AF, Li H, Ke L, Yang C, Liu XY, Yang ZC, et al. Association of 
angiotensin‑converting enzyme insertion/deletion polymorphism with 
susceptibility to systemic lupus erythematosus: a meta‑analysis. Int J 
Rheum Dis. 2018;21(2):447–57.
 26. Tejpal S, Sanghera N, Manoharan V, Planas‑Iglesias J, Bastie CC, Klein‑
Seetharaman J. Angiotensin converting enzyme (ACE): a marker for 
personalized feedback on dieting. Nutrients. 2020;12(3):660.
 27. Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. 
Renin‑angiotensin‑aldosterone system inhibitors and risk of COVID‑19. N 
Engl J Med. 2020. https ://doi.org/10.1056/NEJMo a2008 975.
 28. Dang Y, Zhou T, Hao L, Cao J, Sun Y, Pan D. In vitro and in vivo stud‑
ies on the angiotensin‑converting enzyme inhibitory activity pep‑
tides isolated from broccoli protein hydrolysate. J Agric Food Chem. 
2019;67(24):6757–64.
 29. Gharehbeglou P, Jafari SM. Antioxidant components of brassica vegeta‑
bles including turnip and the influence of processing and storage on 
their anti‑oxidative properties. Curr Med Chem. 2019;26(24):4559–72.
 30. Patra JK, Das G, Paramithiotis S, Shin HS. Kimchi and other widely con‑
sumed traditional fermented foods of Korea: a review. Front Microbiol. 
2016;7:1493.
 31. Ahtesh FB, Stojanovska L, Apostolopoulos V. Anti‑hypertensive peptides 
released from milk proteins by probiotics. Maturitas. 2018;115:103–9.
 32. Santulli G, Pascale V, Finelli R, Visco V, Giannotti R, Massari A, et al. We 
are what we eat: impact of food from short supply chain on metabolic 
syndrome. J Clin Med. 2019;8(12):2061.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
